PHAR vs ISPH
Egyptian International Pharmaceuticals (EIPICO) and Ibnsina Pharma are nearly tied on the Fouda Score (49 vs 46) and sit in the same sector, a gap too small to separate one technical setup from the other. Egyptian International Pharmaceuticals (EIPICO) is higher by a hair as of this page's latest update.
Side-by-Side
| Factor | PHAR | ISPH |
|---|---|---|
| Full name | Egyptian International Pharmaceuticals (EIPICO) | Ibnsina Pharma |
| Sector | Healthcare | Healthcare |
| Fouda Score | 49 | 46 |
| Category | Neutral | Neutral |
| Signal | Weakening Trend | Weakening Trend |
| Price | 114.10 EGP | 11.70 EGP |
| Today's change | +0.53% | +0.00% |
FAQ
PHAR or ISPH, which is stronger by Fouda Score?
The stock with the higher Fouda Score (blending trend, momentum, relative strength and volatility) has the clearer technical setup as of the latest update. Check the table above for the current scores. This is quantitative analysis, not investment advice.
Does it matter if both are in the same sector?
If both sit in the same sector the comparison is fairer, since they react to the same market forces and the score gap reflects company strength. In different sectors you should also weigh each sector trend.
Is the comparison data live?
No. This page refreshes once a day, so its scores and prices can be from an earlier session. Open each stock page for the current figures and deeper detail.